Vygenerované: 14.03.2026 21:58:17
Súhrn: Conducted by researchers from several Brazilian institutions and one Italian institution, the study consolidates molecular, clinical, and epidemiologic evidence documenting detection of viral RNA in placenta, amniotic fluid, and fetal tissues including central nervous system tissue from pregnant women infected in the first trimester Five confirmed cases of vertical transmission of Oropouche virus — all fatal and showing a consistent pattern of central nervous system malformations — establish the pathogen as an obstetric concern that requires changes to prenatal protocols in areas where the virus is endemic, according to a review published in the Journal of Maternal-Fetal & Neonatal Medicine The malformation pattern includes microcephaly, ventriculomegaly, corpus callosum dysgenesis, posterior fossa abnormalities, and arthrogryposis.
Doplnenie: Based on these findings, the review recommends molecular testing for symptomatic pregnant women, serial ultrasonography with focused neurosonography, and mandatory reporting of all suspected or confirmed cases — measures that should be implemented immediately in prenatal services that serve regions with documented Oropouche circulation.
Súhrn: TOPLINE: Ultrahigh-resolution (UHR) photon-counting detector (PCD)-CT demonstrated more than 90% accuracy in detecting coronary in-stent restenosis (ISR), outperforming standard-resolution reconstructions, with improvements in assessing small-calibre stents (below 3 mm in diameter), according to a retrospective study METHODOLOGY: - Researchers conducted a retrospective analysis including 50 consecutive patients with 106 coronary stents (mean age, 70 9 years; 16% women) who underwent UHR coronary CT angiography (CCTA) at two academic centres between May 2023 and 2025.
Doplnenie: - All scans were reconstructed with UHR imaging parameters at a slice thickness of 0.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry USFDA Expands Use of GSK's RSV Vaccine Arexvy to Adults 18-49 at Risk Bengaluru: British drugmaker GSK said on Friday the U Food and Drug Administration has expanded the approved age range for its respiratory syncytial virus vaccine, Arexvy, to include adults aged 18 to 49 who are at increased risk of lower respiratory tract disease caused by the virus for preventing RSV-related disease in adults aged 60 and above, and in at-risk adults aged 50 to 59.
Doplnenie: for preventing RSV-related disease in adults aged 60 and above, and in at-risk adults aged 50 to 59.
Súhrn: METHODOLOGY: - Researchers conducted a cross-sectional analysis of the National FinHealth 2017 Study to assess associations between the consumption of fermented dairy products and metabolic syndrome among adults TOPLINE: Among adults, a higher consumption of fermented dairy products (excluding cheese) was associated with lower odds of metabolic syndrome in men However, in women, the consumption of cheese was linked to a favourable lipid profile and lower odds of metabolic syndrome, whereas a high consumption of milk was linked to higher odds of metabolic syndrome.
Doplnenie: - They analysed data of 5096 adults including 2250 men and 2846 women (mean age, 56 years for both) who had administered a food frequency questionnaire.